Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionTrilogy Capital Inc.
Latest Disclosed Ownership31,249 shares
Latest Disclosed Value $ 4,355,126
Trilogy Capital Inc. reports 5.20% increase in ownership of GILD / Gilead Sciences, Inc.

On April 21, 2026 - Trilogy Capital Inc. filed a 13F-HR form disclosing ownership of 31,249 shares of Gilead Sciences, Inc. (CH:GILD) valued at $4,355,126 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 29,703 shares of Gilead Sciences, Inc.. This represents a change in shares of 5.20% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F GILEAD SCIENCES COM 375558103 31,249 1,546 5.20 4,355 19.48 0.1886
2026-01-22 2025-12-31 13F GILEAD SCIENCES COM 375558103 29,703 2,204 8.01 3,646 19.43 0.1629
2025-10-24 2025-09-30 13F GILEAD SCIENCES COM 375558103 27,499 -48 -0.17 3,052 -0.07 0.1410
2025-07-18 2025-06-30 13F GILEAD SCIENCES COM 375558103 27,547 -5,700 -17.14 3,054 -18.01 0.1485
2025-05-07 2025-03-31 13F GILEAD SCIENCES COM 375558103 33,247 -4,060 -10.88 3,725 8.10 0.1954
2025-01-27 2024-12-31 13F GILEAD SCIENCES COM 375558103 37,307 -3,765 -9.17 3,446 0.09 0.1772
2024-10-21 2024-09-30 13F GILEAD SCIENCES COM 375558103 41,072 -235 -0.57 3,444 21.49 0.1736
2024-07-23 2024-06-30 13F GILEAD SCIENCES COM 375558103 41,307 3,191 8.37 2,834 1.54 0.1538
2024-04-17 2024-03-31 13F GILEAD SCIENCES COM 375558103 38,116 33,202 675.66 2,792 601.26 0.1606
2024-01-12 2023-12-31 13F GILEAD SCIENCES COM 375558103 4,914 -458 -8.53 398 -1.00 0.0246
2023-10-16 2023-09-30 13F GILEAD SCIENCES COM 375558103 5,372 -419 -7.24 403 -13.73 0.0273
2023-07-24 2023-06-30 13F GILEAD SCIENCES COM 375558103 5,791 742 14.70 467 11.48 0.0298
2023-04-17 2023-03-31 13F GILEAD SCIENCES COM 375558103 5,049 -23,304 -82.19 419 -82.83 0.0298
2023-02-09 2022-12-31 13F GILEAD SCIENCES COM 375558103 28,353 -2,602 -8.41 2,434 27.43 0.1727
2022-10-21 2022-09-30 13F GILEAD SCIENCES COM 375558103 30,955 3,632 13.29 1,910 13.08 0.1712
2022-07-20 2022-06-30 13F GILEAD SCIENCES COM 375558103 27,323 6,079 28.62 1,689 33.73 0.1470
2022-04-08 2022-03-31 13F GILEAD SCIENCES COM 375558103 21,244 4,284 25.26 1,263 2.60 0.0906
2022-01-18 2021-12-31 13F GILEAD SCIENCES COM 375558103 16,960 757 4.67 1,231 8.75 0.0923
2021-10-15 2021-09-30 13F GILEAD SCIENCES COM 375558103 16,203 19 0.12 1,132 2.72 0.0861
2021-07-14 2021-06-30 13F GILEAD SCIENCES COM 375558103 16,184 6,318 64.04 1,102 72.73 0.0811
2021-04-12 2021-03-31 13F GILEAD SCIENCES COM 375558103 9,866 741 8.12 638 19.92 0.0488
2021-02-05 2020-12-31 13F GILEAD SCIENCES COM 375558103 9,125 46 0.51 532 -7.32 0.0435
2020-11-16 2020-09-30 13F GILEAD SCIENCES COM 375558103 9,079 -360 -3.81 574 -22.12 0.0549
2020-07-22 2020-06-30 13F GILEAD SCIENCES COM 375558103 9,439 1,473 18.49 737 15.70 0.0729
2020-04-28 2020-03-31 13F GILEAD SCIENCES COM 375558103 7,966 7,966 637 0.0705
2019-04-16 2019-03-31 13F GILEAD SCIENCES COM 375558103 0 -3,903 -100.00 0 -100.00
2019-01-15 2018-12-31 13F GILEAD SCIENCES COM 375558103 3,903 -3,427 -46.75 244 -56.89 0.0328
2018-10-31 2018-09-30 13F GILEAD SCIENCES COM 375558103 7,330 -844 -10.33 566 -2.25 0.0700
2018-08-17 2018-06-30 13F GILEAD SCIENCES COM 375558103 8,174 -468 -5.42 579 -11.20 0.0779
2018-05-24 2018-03-31 13F GILEAD SCIENCES COM 375558103 8,642 8,642 652 0.0945
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.